MapHabit, Inc. is exploring the efficacy of gamification in its assistive technology aimed at individuals with mild to moderate Alzheimer's disease and related dementias. The market for dementia care technologies is expanding, driven by an increasing aging population and a growing need for innovative solutions to improve patient engagement and caregiver support. The competitive landscape includes various digital health solutions targeting dementia care, but few incorporate gamification as a core feature. Successful outcomes from this trial could position MapHabit favorably in the market, potentially leading to partnerships or acquisition interest from larger healthcare companies. Diligence should focus on the scalability of the technology and the regulatory landscape, given that the MapHabit system is not classified as a regulated medical device.